THThomas Hill

Thomas Hill

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Thomas Hill has a total of 61 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Chemosensory tobacco product toxicology part 1: sensory mechanisms

    by Weihong Lin, Thomas Hill, Andrea M Stroup, Samantha Emma Sarles, Tatsuya Ogura, Farhan Augustine, Sean O'SUllivan, Irfan Rahman, Risa Robinson, Sairam V Jabba, et al.

    Chemosensory systems detect and discriminate a wide variety of molecules to monitor internal and external chemical environments. They initiate olfactory, gustatory, and chemesthetic sensations; influence human brain cognition and emotion; and guide a wide variety of behaviors essential for survival, including protective reactions, such as avoidance of contaminated foods and potential toxicants. Electronic nicotine delivery systems (ENDS) aerosolize e-liquids for inhaled consumption that typically contain flavorants, propylene glycol, vegetable glycerin, and nicotine. E-liquid aerosols also contain toxicants, such as formaldehyde, acetaldehyde, acrolein, and heavy metals. Chemosensory evaluation of ENDS aerosol plays an essential role in the assessment of whether a product will attract new users of all ages, as well as determining their likely use patterns, perceptions of product harm, satisfaction, and product selection. Nicotine and individual flavorant constituents stimulate multiple sensory receptor systems in complex patterns, initiating distinctive sensory perceptions depending on the chemical properties and quantity in the aerosol. There are limited data on chemosensory evaluation of ENDS aerosols and their influence on ENDS use and protective biologic mechanisms. This two-part manuscript provides an overview of (i) the physiology of the olfactory, gustatory, and chemesthetic chemosensory systems, their detection mechanisms, and their role in protective defenses; and (ii) the in vitro, in vivo, and in silico computer-based methodology available to evaluate ENDS irritants and toxicants, their impact on chemosensory pathways, the current state of the science related to e-liquid and ENDS aerosols, and challenges for future studies and scientific innovation.

  • Chemosensory tobacco product toxicology part 2: toxicological testing, assays, and state of the science

    by Weihong Lin, Thomas Hill, Andrea M Stroup, Samantha Emma Sarles, Tatsuya Ogura, Farhan Augustine, Sean O'SUllivan, Irfan Rahman, Risa Robinson, Sairam V Jabba, et al.

    The toxicologic impacts on the normative function of the chemosensory system and the loss of its contribution to organism protection and homeostasis remain an underrepresented area of interest in the published literature. The impact of chemical constituents in electronic nicotine delivery system e-liquids or aerosols on the chemosensory system is even less known, as are the effects on product selection and use behavior—and this may be an overlooked impact on the public health. This review is a snapshot of the current state of the science and opportunities for improving and increasing the volume of publications in chemosensory toxicology on the potential impacts of tobacco products. The proposed solutions rely on the determination of the scientific community to take advantage of an unexplored field of opportunity. Active research engagement and use of an integrative, risk-driven planning framework to address harmonization and data gaps in neurosensory research programs would support harmonization, improve scientific visibility in the published literature, and recruit additional investigators to this research community.

  • Open Access

    In Vitro assessments of ENDS toxicity in the respiratory tract: Are we there yet?

    by Thivanka Muthumalage, Emma Sarles, Qixin Wang, Edward Hensel, Thomas Hill, Irfan Rahman, Risa Robinson, Andrea M. Stroup, Krista Thongphanh, Lisa A. Miller


  • Addressing Cardiovascular Toxicity Risk of Electronic Nicotine Delivery Systems in the Twenty-First Century: “What Are the Tools Needed for the Job?” and “Do We Have Them?”

    by Mark Chandy, Thomas Hill, Nerea Jimenez-Tellez, Joseph C. Wu, S. Emma Sarles, Edward Hensel, Qixin Wang, Irfan Rahman, Daniel J. Conklin

    Cigarette smoking is positively and robustly associated with cardiovascular disease (CVD), including hypertension, atherosclerosis, cardiac arrhythmias, stroke, thromboembolism, myocardial infarctions, and heart failure. However, after more than a decade of ENDS presence in the U.S. marketplace, uncertainty persists regarding the long-term health consequences of ENDS use for CVD. New approach methods (NAMs) in the field of toxicology are being developed to enhance rapid prediction of human health hazards. Recent technical advances can now consider impact of biological factors such as sex and race/ethnicity, permitting application of NAMs findings to health equity and environmental justice issues. This has been the case for hazard assessments of drugs and environmental chemicals in areas such as cardiovascular, respiratory, and developmental toxicity. Despite these advances, a shortage of widely accepted methodologies to predict the impact of ENDS use on human health slows the application of regulatory oversight and the protection of public health. Minimizing the time between the emergence of risk (e.g., ENDS use) and the administration of well-founded regulatory policy requires thoughtful consideration of the currently available sources of data, their applicability to the prediction of health outcomes, and whether these available data streams are enough to support an actionable decision. This challenge forms the basis of this white paper on how best to reveal potential toxicities of ENDS use in the human cardiovascular system—a primary target of conventional tobacco smoking. We identify current approaches used to evaluate the impacts of tobacco on cardiovascular health, in particular emerging techniques that replace, reduce, and refine slower and more costly animal models with NAMs platforms that can be applied to tobacco regulatory science. The limitations of these emerging platforms are addressed, and systems biology approaches to close the knowledge gap between traditional models and NAMs are proposed. It is hoped that these suggestions and their adoption within the greater scientific community will result in fresh data streams that will support and enhance the scientific evaluation and subsequent decision-making of tobacco regulatory agencies worldwide. Graphical Abstract Models for Cardiovascular Toxicity Testing E-cigarettes and nicotine delivery systems can be examined using multiple model systems. In silico models might predict adverse cardiovascular effects that can be screened for using 2-D and 3-D models using induced pluripotent stem cell (iPSC) derived cardiac tissue and “omics” profiling such as single-cell RNA sequencing (scRNA-seq) or high-throughput functional analysis with a multiple electrode array (MEA). Biologic plausibility of detected effects can be corroborated using ex vivo or in vivo models, which may also lead to the discovery of new biomarkers or treatments for CVD.


  • Adverse outcome pathway-driven identification of rat liver tumorigens in short-term assays

    by John Rooney, Thomas Hill, Chunhua Qin, Frank D. Sistare, J. Christopher Corton


  • Editor’s Highlight: Negative Predictors of Carcinogenicity for Environmental Chemicals

    by Thomas Hill, Mark D. Nelms, Stephen W. Edwards, Matthew Martin, Richard Judson, J. Christopher Corton, Charles E. Wood

    Recent international efforts have led to proposals for modified carcinogenicity testing paradigms based on data from shorter-term studies. The main goal of the current study was to evaluate the negative predictive value (NPV) of short-term toxicity indicators on carcinogenicity study outcomes and cancer classifications for chemicals previously reviewed by the U.S. Environmental Protection Agency (EPA). Pathology data were analyzed from over 900 acceptable 2-sex guideline subchronic (3-month) and carcinogenicity studies in the U.S. EPA Toxicity Reference Database. Chemical cancer classifications were obtained from annual reports of the U.S. EPA Office of Pesticide Programs. Histopathologic risk signals and evidence of hormonal perturbation in subchronic rat studies provided 56% NPV for any tumor outcome in the rat or mouse and 75% NPV for cancer classifications not requiring quantitative risk assessment (qRA). In comparison, lack of activity in a battery of 35 in vitro cytotoxicity assays from the U.S. EPA ToxCast library provided 49% NPV for any tumor outcome and 80% NPV for cancer classifications not requiring qRA. These findings support the idea that the absence of short-term bioactivity may provide useful information for prioritizing chemicals based on potential carcinogenic risk. Additional data streams are needed to further refine these models.


  • The Nature of Insight from Data and Implications for Automated Decisioning

    by Linda A. Winters-Miner, Pat Bolding, Thomas Hill, Bob Nisbet, Mitchell Goldstein, Joseph M. Hilbe, Nephi Walton, Gary Miner, Danny Stout


  • Open Access

    Baseline survey of the anatomical microbial ecology of an important food plant: Solanum lycopersicum (tomato)

    by Andrea R Ottesen, Antonio González Peña, James R White, James B Pettengill, Cong Li, Sarah Allard, Steven Rideout, Marc Allard, Thomas Hill, Peter Evans, et al.

    Research to understand and control microbiological risks associated with the consumption of fresh fruits and vegetables has examined many environments in the farm to fork continuum. An important data gap however, that remains poorly studied is the baseline description of microflora that may be associated with plant anatomy either endemically or in response to environmental pressures. Specific anatomical niches of plants may contribute to persistence of human pathogens in agricultural environments in ways we have yet to describe. Tomatoes have been implicated in outbreaks of Salmonella at least 17 times during the years spanning 1990 to 2010. Our research seeks to provide a baseline description of the tomato microbiome and possibly identify whether or not there is something distinctive about tomatoes or their growing ecology that contributes to persistence of Salmonella in this important food crop. DNA was recovered from washes of epiphytic surfaces of tomato anatomical organs; leaves, stems, roots, flowers and fruits of Solanum lycopersicum (BHN602), grown at a site in close proximity to commercial farms previously implicated in tomato-Salmonella outbreaks. DNA was amplified for targeted 16S and 18S rRNA genes and sheared for shotgun metagenomic sequencing. Amplicons and metagenomes were used to describe “native” bacterial microflora for diverse anatomical parts of Virginia-grown tomatoes. Distinct groupings of microbial communities were associated with different tomato plant organs and a gradient of compositional similarity could be correlated to the distance of a given plant part from the soil. Unique bacterial phylotypes (at 95% identity) were associated with fruits and flowers of tomato plants. These include Microvirga, Pseudomonas, Sphingomonas, Brachybacterium, Rhizobiales, Paracocccus, Chryseomonas and Microbacterium. The most frequently observed bacterial taxa across aerial plant regions were Pseudomonas and Xanthomonas. Dominant fungal taxa that could be identified to genus with 18S amplicons included Hypocrea, Aureobasidium and Cryptococcus. No definitive presence of Salmonella could be confirmed in any of the plant samples, although 16S sequences suggested that closely related genera were present on leaves, fruits and roots.